Hyderabad | Mumbai: One of the local companies developing a Covid-19 vaccine has aired concerns over the absence of guidelines in India for vaccine making and immunisation, as well as funding commitment from the government. India is staring at the risk of losing its competitive advantage in vaccine manufacturing to other countries, Biological E chairperson Mahima Datla said, even as she also complained about lack of enough clinical trial sites